View Older Stories View More Recent Stories

May 29, 2024 03:00AM Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline
May 28, 2024 09:00AM Be Biopharma Announces FDA Clearance of IND Application for BE-101 in Hemophilia B
May 23, 2024 07:03AM Bicycle Therapeutics (BCYC) Announces $555 Million Private Placement Equity Financing
May 23, 2024 07:00AM Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing
May 21, 2024 09:00AM Be Biopharma Expands Scientific Advisory Board with the Appointment of Cell and Gene Therapy Leader Dr. Paula Cannon
May 21, 2024 08:00AM AltruBio Secures up to $225M Oversubscribed Series B Financing to Advance the Clinical Development of Novel Immune Checkpoint Enhancer Program
May 17, 2024 04:31PM Form 13F-HR/A RA CAPITAL MANAGEMENT, For: Mar 31
May 17, 2024 04:19PM Form SC 13D/A Eliem Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2024 05:22PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31
May 15, 2024 04:20PM Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 14, 2024 09:11PM Form SC 13D/A iTeos Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 13, 2024 07:00AM Ajax Therapeutics Raises $95 Million Series C Financing To Advance First-in-Class Type II JAK2 Inhibitor, AJ1-11095, Into The Clinic
May 10, 2024 05:53PM Form SC 13G Medicenna Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
May 10, 2024 12:00PM Be Biopharma Announces New Preclinical Data for Novel B Cell Medicine for the Potential Treatment of Hypophosphatasia
May 10, 2024 08:24AM iTeos Therapeutics (ITOS) Announces $120 Million Registered Direct Offering
May 10, 2024 08:24AM iTeos Therapeutics Announces $120 Million Registered Direct Offering
May 9, 2024 08:49PM Form SC 13D/A Black Diamond Therapeuti Filed by: RA CAPITAL MANAGEMENT, L.P.
May 9, 2024 04:05PM Regulus Therapeutics Reports First Quarter 2024 Financial Results and Recent Updates
May 9, 2024 04:01PM Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results
May 9, 2024 07:00AM Bluejay Therapeutics Secures $182 Million in Series C Financing to Propel Clinical Pipeline
May 8, 2024 08:00AM Jnana Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
May 7, 2024 04:52PM Form SC 13D/A Werewolf Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 6, 2024 05:58PM Form SC 13G Avidity Biosciences, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 6, 2024 08:00AM Sortera Technologies Announces Curt Sacks as Senior Vice President and CFO
May 2, 2024 05:59PM Form SC 13G Zura Bio Ltd Filed by: RA CAPITAL MANAGEMENT, L.P.
May 2, 2024 08:00AM Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update
May 2, 2024 07:08AM Mariana Oncology to be Acquired by Novartis (NVS) to Advance Precision Radiopharmaceuticals to Treat Cancer
May 2, 2024 07:00AM Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer
Apr 30, 2024 04:17PM Form SC 13D/A Aerovate Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 26, 2024 09:38AM Commons Clinic Invests $9.75M in Advanced Spine Surgery Center; Launches Next-Gen Ambulatory Surgical Platform "Theater"
Apr 25, 2024 08:43PM Form SC 13G Protara Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 24, 2024 04:05PM Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Apr 23, 2024 09:00AM Be Biopharma to Present at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Apr 18, 2024 09:22AM Zura Bio (ZURA) Enters $112.5M Private Placement
Apr 18, 2024 09:22AM Zura Bio Announces Oversubscribed $112.5 Million Private Placement
Apr 16, 2024 08:00AM Asher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials
Apr 15, 2024 04:46PM Form SC 13G Surrozen, Inc./DE Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 12, 2024 06:53PM Form SC 13D/A Eliem Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 12, 2024 04:25PM Form SC 13G Boundless Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 11, 2024 07:56PM Form SC 13G CervoMed Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 11, 2024 04:16PM Form SC 13D/A Acrivon Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 11, 2024 07:00AM Eliem Therapeutics (ELYM) to Acquire Tenet Medicines, Announces Concurrent $120M Private Placement
Apr 11, 2024 07:00AM Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
Apr 10, 2024 07:00AM TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline
Apr 9, 2024 07:01AM Acrivon Therapeutics (ACRV) Announces $130 Million Private Placement Financing
Apr 9, 2024 07:00AM Acrivon Therapeutics Announces $130 Million Private Placement Financing
Apr 8, 2024 12:00PM Adela Presents Data Demonstrating Ability of Tissue-Agnostic MRD Assay to Predict Recurrence in Head & Neck Cancer at the American Association for Cancer Research Annual Meeting 2024
Apr 5, 2024 08:05AM Protara Therapeutics (TARA) Announces $45M Private Placement at $4.15/sh
Apr 5, 2024 08:04AM Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing
Apr 4, 2024 07:05PM Form SC 13G Dyne Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
View More Recent Stories View Older Stories